title: Coagulase-negative staphylococcal sepsis as a predictor of bronchopulmonary dysplasia.
abstract: OBJECTIVE
  To determine whether sepsis caused by coagulase-negative staphylococci (CoNS) is a risk factor for developing bronchopulmonary dysplasia (BPD) in premature newborns.
  
  
  METHODS
  All newborns born at < or = 30 wk of gestation at Orebro University Hospital during 1994-2001 with clinical sepsis caused by CoNS (group A, n = 22) or by other bacteria (group B, n = 17) were included and compared with premature newborns without sepsis (group C, n = 53). Clinical sepsis was defined as a positive blood culture (monoculture) plus clinical symptoms and laboratory findings. BPD was defined as treatment with oxygen > 21% for at least 28 d.
  
  
  RESULTS
  The incidence of BPD differed between the three groups, as follows: CoNS sepsis (A) 64%, other sepsis (B) 41% and control (C) 24%. The difference between the control group and the sepsis groups was highly significant (p = 0.006). In a univariate model the crude estimates of relative risk (RR) for occurrence of BPD increased with presence of sepsis and particularly with presence of sepsis with CoNS (A: RR 2.6, 95% CI 1.5-4.6, p = 0.001; B: RR 1.7, CI 0.8-3.5, p = 0.17). When regression was performed with two additional predictive variables in multivariate models including sepsis, gestational age and mechanical ventilation (group A: RR 1.5, CI 1.1-2.0, p = 0.004; group B: RR 0.9, CI 0.6-1.4, p = 0.67), the estimates were lower.
  
  
  CONCLUSIONS
  The relative risk for BPD is significantly increased in premature newborns with sepsis caused by CoNS compared with those with sepsis caused by other bacteria and compared with premature newborns with no sepsis.
authors.affiliation: Department of Paediatrics, Orebro University Hospital, SE-70185 Orebro, Sweden. magnus.liljedahl@orebroll.se
authors.forename: Magnus
authors.initials: M
authors.lastname: Liljedahl
authors.forename: L
authors.initials: L
authors.lastname: Bodin
authors.forename: J
authors.initials: J
authors.lastname: Schollin
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use; D001997:Bronchopulmonary Dysplasia / Q000097:blood* / Q000175:diagnosis* / Q000453:epidemiology; D003030:Coagulase / Q000097:blood*; D003937:Diagnosis, Differential; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D011175:Positive-Pressure Respiration / Q000379:methods; D011237:Predictive Value of Tests; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency / Q000453:epidemiology / Q000628:therapy; D012189:Retrospective Studies; D013203:Staphylococcal Infections / Q000097:blood* / Q000175:diagnosis* / Q000453:epidemiology; D018746:Systemic Inflammatory Response Syndrome / Q000097:blood* / Q000175:diagnosis* / Q000453:epidemiology
chemical_list: D000890:Anti-Infective Agents; D003030:Coagulase